Ethical analysis of the risk-benefit issue in recombinant DNA research and technology.
D001327:Autoimmune Diseases / Q000150:complications; D003264:Containment of Biohazards; D004274:DNA, Recombinant; D004777:Environment; D004992:Ethics, Medical; D005069:Evaluation Studies as Topic; D015386:Hazardous Substances; D006801:Humans; D007757:Laboratory Infection; D009316:National Institutes of Health (U.S.); D011336:Probability; D012106:Research; D012306:Risk; D018570:Risk Assessment; D014481:United States